Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

OncoTargets and Therapy

  • h-index: 102
  • Total citations: 135,758
  • Total papers: 6,309
  • Impact factor: 1.955621301775148

Homepage: http://www.dovepress.com/oncotargets-and-therapy-journal

OncoTargets and Therapy

Journal
Visit website →
H-Index = 102
Citations = 135.76K+

Papers

Evidence

Recent papers in OncoTargets and Therapy

  1. Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate?OncoTargets and Therapy · Mon,
  2. The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell SubsetsOncoTargets and Therapy · Mon,
  3. The Dual Role of RBBP7 in Esophageal Squamous Cell Carcinoma: Cell Context-Dependent Impacts on Proliferation and RadiosensitivityOncoTargets and Therapy · Mon,
  4. Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors – A Systematic Review and Meta-AnalysisOncoTargets and Therapy · Tue,
  5. The Expression and Clinical Significance of ALDOA in Breast CancerOncoTargets and Therapy · Fri,
  6. Advances in ORMDL Research in Malignant Tumors: A ReviewOncoTargets and Therapy · Tue,
  7. Upregulation of SHIP2 Participates in the Development of Breast Cancer via Promoting Wnt/β-Catenin Signaling RetractionOncoTargets and Therapy · Fri,
  8. CD93: A Promising NETs-Related Biomarker for Diagnosis and Therapy in Actinic KeratosisOncoTargets and Therapy · Fri,
  9. Immunotherapy Resistance and Therapeutic Strategies in PD-L1 High Expression Non-Small Cell Lung CancerOncoTargets and Therapy · Fri,
  10. Migrasome-Related Prognostic Genes in Gastric Cancer: A Transcriptomic and Immunotherapeutic AnalysisOncoTargets and Therapy · Fri,

About OncoTargets and Therapy

OncoTargets and Therapy carries 6,309 indexed papers, 135,758 citations, h-index 102 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), OncoTargets and Therapy sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at http://www.dovepress.com/oncotargets-and-therapy-journal.

Use the feed below to follow new OncoTargets and Therapy publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 105 words.